Our group
Our commitments
Our strategy
Our divisions
Pharmagest
Axigate Link
Medical Solutions
e-Connect
Fintech
Solutions
Finance
Agenda
Financial Analyses
Shareholders’ meetings
Documentation
Press releases
Financial contact
Voting Rights
Shareholders
Corporate Governance
Regulated information
L’Action Equasens
Durabilité
en
fr
Search
Search
Accueil
/
Q1 2022 revenue: +9.03% to €49.36m
Q1 2022 revenue: +9.03% to €49.36m
